Roy Exum: My Pimples And Andrea Sloan

Monday, September 30, 2013 - by Roy Exum
Roy Exum
Roy Exum

A real long time ago I was having a fit with acne. I was a lovelorn teenager, infatuated with pretty girls in a dizzy game where pimples can really become cumbersome. It seemed like nothing was working and, after I grew a pimple large enough for its own zip code, I finally found a genius doctor who quickly became my lifelong hero when he came up with a marvelous idea.

At the time there was a new “super drug”  that was languishing through years of “clinical trials” in the United States and nobody could get any, despite the fact the revolutionary medicine was already available in Germany. My hero called up a close friend who was a German doctor and – presto! – the first 250 pills came flying across the ocean.

I had to promise that I would not sue anybody if I grew an extra set of ears, developed female breasts, or my eyes turned yellow, but, honestly, I would have dyed my hair green to get the American-made medicine. After I took a course of what was then identified by only a strange laboratory number, my pimples and my acne were gone forever. I had Clark Gable looks and never looked back. That’s a true story (except the Gable part.)

Other fellow Americans had to wait for many months. I don’t believe that's right. Since this occurred in my formative years, I have cursed the federal Food and Drug Administration for much of my adult life because the “clinical trials” process we use is horribly dysfunctional and in critical need of an overhaul.

To illustrate my point, allow me to introduce a beautiful Texas lawyer, Andrea Sloan. Yes, she is quite pretty but “beautiful” because her career has been as the executive director of a Texas advocacy project that provides free legal services to low-income victims of domestic or sexual abuse.

Andrea is a victim herself, not just of stage 3c ovarian cancer but a horribly-tangled FDA system. Her doctors have exhausted every known method to save her life. Six years of surgery, radiation, and chemotherapy haven’t worked. She’s still very much a patient at the world-famous M.D. Anderson Medical Center and her oncologist believes an experimental drug called “BMN 673” might well save Andrea’s life.

M.D. Anderson has a good supply of BMN 673 on hand but with millions of dollars at stake, the manufacturer, BioMarin in California, has said no. “It would be unethical and reckless to provide end-stage refractory ovarian cancer patients outside clinical trial with BMN 673 at this early stage of development,” said spokesperson Debra Charlesworth.

“If we did,” Charlesworth explained to CNN, “we would be exposing the experimental drug to a large group without adequate testing. There have been previous circumstances where early access to large groups has resulted in adverse consequences that were worse than the course of the disease.”

I am certain no scientist can hardly wait for somebody to try to explain to me what “adverse consequences” could possibly be worse than what Andrea Sloan is facing without BMN 673. Andrea is pleading for the drug – let the petals of the flower fall where they may – and probably understands the risks as much as anyone involved. She knows what will happen if she fails to get BMN 673 better than anyone else, too.

Here is what she wrote in a statement to the drug company: “I recognize the importance of weighing the risk and the myriad of considerations they face as a company. However, this is a risk worth taking. I will thank them. My family will thank them. An amazing army of loyal supporters, to whom I owe a debt of gratitude, will thank them. In America we do not leave our wounded warriors on the battleground. BioMarin, please be the Calvary that saves me.”

Her M.D. Anderson doctors believe Andrea is a great candidate. Further, the FDA itself has just announced Ms. Sloan qualifies for a “compassionate care” waiver in the rules but the manufacturer, BioMarin, still says no. The word is BioMarin stands to make about $500 million on the drug and, even though they say they plan to give away 10 percent of the medicine to charity, they refuse to face the ethical dilemma.

As of Sunday afternoon Andrea had almost 170,000 supporters on her webpage and politician Newt Gingrich, co-host of CNN’s “Crossfire” program, is irate at “a corporation protecting its wallet at the expense on Andrea’s possibly dying. If you want to know why big companies often get bad names, it’s explaining that clerical support to fill out FDA paperwork is too difficult when you can save a life.”

Dr. Charles Levenback, Andrea’s doctor, is disappointed at BioMarin’s stance but, as a man who sees the fight against cancer every day, he told CNN reporters, “My own belief is that the drug companies, the manufacturers, the insurance companies, the providers like my hospital M.D. Anderson, the individual medical professionals, the investigators, the patients -- everybody wants the same things. Safe, effect, novel therapies for as many people as it's appropriate for. Even BioMarin, I believe. I don't think this is like 'Let the masses eat cake.' I think they're on the same mission. But the whole system is giving this dysfunctional result."

On Andrea Sloan’s Facebook page there is a picture that tells of “Three Simple Rules.” The text reads, “If you don’t go after what you want in life, you will never have it. If you don’t ask, the answer will always be No. If you don’t step forward, you’ll always be in the same place.”

Those three rules got rid of my pimples but all we can do is pray for Andrea Sloan. She needs it right now.

Make Government Work Again

There hasn't been as much talk about it in the national news as the presidential candidates, but please don't forget the down race ballots, our do-nothing Congress and the obstructionism they have practiced over the last eight years. It is time to break the log jam and make government work again. That includes the state level as well.  John Fricke (click for more)

Joe Smith Will Be Our Watchdog

I am writing as a registered Democratic voter asking that all voters, regardless of party affiliation, vote for Independent Candidate Joe Smith for District 3 Hamilton County commissioner.  The Hamilton County Commission is the local legislative branch of our county government and their duties include making policies, ordinances, appropriating funds and many other things ... (click for more)

In Surprise Vote, Chattanooga City Council Turns Down Short Term Vacation Rentals

In a surprise vote, the City Council on Tuesday night turned down allowing a process to legalize short term vacation rentals in Chattanooga. Only Chip Henderson and Jerry Mitchell voted in favor. Opposed were Carol Berz, Yusuf Hakeem, Larry Grohn, Moses Freeman, Ken Smith and Russell Gilbert. Chris Anderson was absent. Afterward, Councilman Smith said, in light of the vote, ... (click for more)

Cold Case Unit Makes Arrest In Murders Of Brothers In Brainerd Almost 20 Years Ago; Detectives Say Brainerd Jeweler Rick Davis Tied To Incident

The Cold Case Unit set up by District Attorney Neal Pinkston has made an arrest in the murders of two brothers in Brainerd almost 20 years ago. The Hamilton County Grand Jury on Monday indicted 52-year-old Christopher Jeffre Johnson on two counts of first-degree murder in the January 1997 deaths of Sean and Donny Goetcheus. The 25-year-old Sean Goetcheus and his ... (click for more)

Taylor Luthringer, Thomas Porter Win Region Cross Country

COOKEVILLE – Tuesday was a pretty good day for the Signal Mountain cross country teams. Not only did they celebrate with both individual winners in the Region 4-A/AA races, but both teams finished in the top three and will advance to the state meet, which will be held at Nashville’s Percy Warner Park a week from Saturday. Taylor Luthringer and Thomas Porter captured the individual ... (click for more)

Notre Dame Draws Top Ranked Greeneville, CCS Opens With Madison Magnet

For the second year in a row, Notre Dame drew the top-ranked Greeneville in the opening round of the TSSAA Class A/AA state tournament.  Notre Dame is scheduled to play Greeneville on Wednesday at 8 p m. (EST)  in Murfreesboro. CCS will play Madison Magnet in the first round on field #1 at 7:30 p.m. (EST) . CCS and Greeneville met in the state championship game ... (click for more)